Literature DB >> 6871081

Dexamethasone and radiation response in the Lewis lung tumour model.

O O Agboola, J A Raleigh, J E Pedersen, R C Urtasun, G Barron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871081      PMCID: PMC2011413          DOI: 10.1038/bjc.1983.162

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

Review 1.  Corticosteroids: clinical pharmacology and therapeutic use.

Authors:  S L Swartz; R G Dluhy
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

2.  The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.

Authors:  T H Wasserman; T L Phillips; G Van Raalte; R Urtasun; J Partington; D Koziol; J G Schwade; D Gangji; J M Strong
Journal:  Br J Radiol       Date:  1980-02       Impact factor: 3.039

3.  The effect of dexamethasone on the radiation survival response and misonidazole-induced hypoxic-cell cytotoxicity in Chinese hamster cells V-79-753B in vitro.

Authors:  B C Millar; S Jinks
Journal:  Br J Radiol       Date:  1981-06       Impact factor: 3.039

4.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

5.  Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.

Authors:  M D Walker; T A Strike
Journal:  Cancer Clin Trials       Date:  1980

6.  High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.

Authors:  R C Urtasun; H Tanasichuk; D Fulton; O Agboola; A R Turner; D Koziol; J Raleigh
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982 Mar-Apr       Impact factor: 7.038

7.  High performance liquid chromatographic assay of dexamethasone in plasma and tissue.

Authors:  B E Cham; B Sadowski; J M O'Hagan; C N de Wytt; F Bochner; M J Eadie
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.